Oramed Pharmaceuticals ORMP

$ 2.38 -4.22%

Quarterly report 2024-Q3
added 11-07-2024

Oramed Pharmaceuticals Cash and Cash Equivalents 2011-2024 | ORMP

Annual Cash and Cash Equivalents Oramed Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
9.06 M	40.5 M	27.5 M	19.3 M	3.33 M	5 M	3.97 M	3.91 M	3.21 M	1.76 M	2.27 M	4.43 M	1.51 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
40.5 M	1.51 M	9.67 M

Quarterly Cash and Cash Equivalents Oramed Pharmaceuticals

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
42.1 M	10 M	18.6 M	9.06 M	5.47 M	6.77 M	24.1 M	40.5 M	33.2 M	29.9 M	28 M	27.5 M	84.4 M	79.6 M	33.8 M	14.9 M	19.3 M	19.3 M	14.9 M	3.17 M	3.33 M	3.33 M	3.17 M	3.86 M	5 M	5 M	3.86 M	1.26 M	3.97 M	3.97 M	1.26 M	2.29 M	3.91 M	3.91 M	2.29 M	1.95 M	3.21 M	3.21 M	1.95 M	6.66 M	1.76 M	1.76 M	6.66 M	1.37 M	2.27 M	2.27 M	1.37 M	5.53 M	4.43 M	4.43 M	5.53 M	1.5 M	1.51 M	1.51 M	1.5 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
84.4 M	1.26 M	11.9 M